Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05155956 · ClinicalTrials.gov registry record

Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System

A clinical trial of Thoracic Aortic Aneurysm and Thoracic Aortic Dissection, sponsored by University of Pennsylvania.

Active
Registry status
20
Enrollment target
2
Study locations

NCT05155956: Active study of Thoracic Aortic Aneurysm and Thoracic Aortic Dissection, sponsored by University of Pennsylvania.

NCT05155956 is a study of Thoracic Aortic Aneurysm and Thoracic Aortic Dissection that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 20 participants, below the 909-participant average among 7 other Thoracic Aortic Aneurysm trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05155956, a study of Thoracic Aortic Aneurysm and Thoracic Aortic Dissection, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
20 participants
Enrollment target
2
Study locations

Study Summary

This is an observational cohort study addressing the incidence of cerebral microemboli and alterations of cerebral hemodynamic physiology of the Relay®Branch thoracic stent-graft system.

Primary Outcome

TCD

Interventions

  • OTHER transcranial Doppler ultrasonography (TCD)

Study Locations (2)

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia
  • Penn Presbyterian Medical Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-12-15
Est. Completion 2026-12
University of Pennsylvania

1,423 total trials

What the registry record for NCT05155956 still lists

NCT05155956 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 909-participant average among 7 other Thoracic Aortic Aneurysm trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Thoracic Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which transcranial Doppler ultrasonography (TCD) is the first listed.

NCT05155956 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05155956 about?

NCT05155956 is a clinical study titled "Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System". This is an observational cohort study addressing the incidence of cerebral microemboli and alterations of cerebral hemodynamic physiology of the Relay®Branch thoracic stent-graft system.

What is the current status of trial NCT05155956?

This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2021-12-15. Estimated completion is 2026-12.

What conditions does trial NCT05155956 study?

This clinical trial studies the following conditions: Thoracic Aortic Aneurysm, Thoracic Aortic Dissection, Microemboli.

What interventions are being tested in trial NCT05155956?

The interventions under investigation include: transcranial Doppler ultrasonography (TCD) (OTHER).

Who is sponsoring clinical trial NCT05155956?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05155956 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thoracic Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05155956, the US trial registry maintained by the National Library of Medicine. NCT05155956 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.